Funding · Company
TMRW Life Sciences, Inc.
New York, NYHealthcare
TMRW Life Sciences, Inc. of New York, NY has disclosed $167M across 3 Form D offerings filed with the SEC between May 13, 2022 and Apr 24, 2026.
$167M
Total disclosed
3
Form D offerings
2018
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$28M
Form D · Jul 12, 2024 ↗
Q3 2024
· target $30M
$100M
Form D · May 13, 2022 ↗
Q2 2022
· 1 amendment, first filed Jul 15, 2021
· target $102M
Filing details
HeadquartersNew York, NYIndustryHealthcare (Other Health Care)Incorporated2018SEC CIK0001759388Offerings on file3
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →